UFLEX Limited (UFLEX)
Earnings Presentation
AI summary
- Q1 FY27 consolidated revenue Rs 53,972 mn +37.6% YoY, EBITDA Rs 9,198 mn +92.1% YoY, PAT Rs 4,233 mn +629.6% YoY
- EBITDA margin expanded to 17.0%, highest in 21 quarters, driven by overseas businesses and improved product mix
- Capex of Rs 4,782 mn in Q1 FY27 across Egypt aseptic, Mexico WPP bags, Noida recycling, and Dharwad BOPP line
- Packaging films volumes grew 6.4% QoQ and 4.9% YoY; packaging volumes declined reflecting strategic shift
- New facilities commissioned: Noida recycling (Apr 2026), Mexico WPP bags (Jul 2026); Egypt aseptic facility commissioning H1 FY27
- Industry trends: India FMCG volumes recovering; global demand shaped by West Asia crisis and trade policies
- Management expects sustained profitable growth in FY27 supported by capacity expansion, technology, and operational efficiency
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 UFLEX — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add UFLEX to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on UFLEX Limited
Important.
The summary above is generated automatically from UFLEX Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.